口服链球菌制剂“OK-432”——第四篇报告：对移植盲肠肿瘤小鼠体外抗肿瘤免疫反应的增强作用 - Suppr | 超能文献

[Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].

作者信息

Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T

出版信息

Nihon Gan Chiryo Gakkai Shi. 1984 Oct 20;19(9):2179-87.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].口服链球菌制剂“OK-432”——第四篇报告：对移植盲肠肿瘤小鼠体外抗肿瘤免疫反应的增强作用

Nihon Gan Chiryo Gakkai Shi. 1984 Oct 20;19(9):2179-87.

2

[Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].[口服链球菌制剂“沙培林”的实验研究。第六篇报告：对移植盲肠肿瘤小鼠体内抗肿瘤免疫的影响]

Nihon Gan Chiryo Gakkai Shi. 1985 Apr 20;20(3):609-17.

3

[The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].[OK-432的口服给药。第5份报告：对移植盲肠肿瘤小鼠的淋巴细胞增殖反应和自然杀伤细胞活性的影响]

Nihon Gan Chiryo Gakkai Shi. 1985 Apr 20;20(3):597-608.

4

[Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].[口服链球菌制剂“沙培林”的实验研究。第三次报告：对小鼠肠系膜淋巴结自然杀伤活性及对丝裂原的淋巴细胞增殖反应的增强作用]

Nihon Gan Chiryo Gakkai Shi. 1984 May 20;19(4):803-10.

5

[Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].经肠道给予OK-432-MCT乳剂对小鼠肺转移的抑制作用

Nihon Gan Chiryo Gakkai Shi. 1988 Jun 20;23(6):1300-6.

6

[Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].[链球菌制剂OK-432给药途径的评估——特别提及自然杀伤细胞活性的增强]

Nihon Gan Chiryo Gakkai Shi. 1982 Dec 20;17(8):2044-55.

7

[Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].[通过腹腔内和瘤内联合注射溶链菌制剂预防腹膜复发]

Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 2):1596-9.

8

[Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].[一周间隔的放疗与两次瘤内注射溶链菌制剂联合应用对小鼠纤维肉瘤（NFSA）的作用]

Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 1):631-5.

9

[Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].

Gan To Kagaku Ryoho. 1987 Sep;14(9):2710-5.

10

Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.用OK-432诱导的杀伤细胞对荷瘤小鼠进行过继性免疫治疗。

Jpn J Exp Med. 1988 Apr;58(2):109-14.

引用本文的文献

1

Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.口服链球菌制剂OK-432（皮西巴尼）的抗肿瘤作用——对乙基亚硝基脲诱导的大鼠胃肠道肿瘤致癌作用和生长的抑制

Jpn J Surg. 1990 May;20(3):316-26. doi: 10.1007/BF02470667.